All News ImpediMed Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:51 2024-05-20 am EDT			5-day change	1st Jan Change
0.09 ^AUD	+1.12%		+13.92%	-37.93%

Apr. 30	ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	MT
Apr. 30	Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024

Ord Minnett rates IPD as Speculaitve Buy	Apr. 30	AQ
Morgans rates IPD as Speculative Buy	Apr. 30	AQ
ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	Apr. 29	MT
Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024	Apr. 29
Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	Apr. 16	MT
Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16	Apr. 16	MT
ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	Apr. 11	CI
ImpediMed Limited(ASX:IPD) added to S&P/ASX All Ordinaries Index	Mar. 17	CI
Impedimed Names Independent Non-Executive Chair	Feb. 27	MT
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	Feb. 26	MT
Transcript : ImpediMed Limited, H1 2024 Earnings Call, Feb 27, 2024	Feb. 26
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 26	CI
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	Feb. 14	MT
Transcript : ImpediMed Limited, Q2 2024 Earnings Call, Feb 01, 2024	Jan. 31
Transcript : ImpediMed Limited - Shareholder/Analyst Call	Nov. 29
ImpediMed CEO, CFO Step Down; Shares Fall 11%	Nov. 19	MT
ImpediMed Limited Announces CEO Changes	Nov. 19	CI
ImpediMed Limited Announces CFO Changes	Nov. 19	CI
ImpediMed Limited Announces Management Changes	Nov. 19	CI
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	Nov. 02	MT

No results for this search